Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02389634 · ClinicalTrials.gov registry record
Identification of Novel Molecular Markers for Vasospasm
A clinical trial of Subarachnoid Hemorrhage and Cerebral Vasospasm, sponsored by St. Joseph's Hospital and Medical Center, Phoenix.
- Completed
- Registry status
- 50
- Enrollment target
- 1
- Study location
NCT02389634: Completed study of Subarachnoid Hemorrhage and Cerebral Vasospasm, sponsored by St. Joseph's Hospital and Medical Center, Phoenix.
NCT02389634 is a study of Subarachnoid Hemorrhage and Cerebral Vasospasm that has completed, run by St. Joseph's Hospital and Medical Center, Phoenix. The registered enrollment target is 50 participants, below the 3,585-participant average among 21 other Subarachnoid Hemorrhage trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02389634, a study of Subarachnoid Hemorrhage and Cerebral Vasospasm, has completed, sponsored by St. Joseph's Hospital and Medical Center, Phoenix.
- COMPLETED
- Registry status
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of the study is to identify novel genetic and protein markers for the process of cerebral vasospasm following aneurysmal subarachnoid hemorrhage.
Primary Outcome
Identification of vasospasm via microRNA mediators prior to clinically evident signs and symptoms
Conditions Studied
Study Locations (1)
Arizona
- Barrow Neurological Institute at St. Joseph's Hospital and Medical Center - Phoenix
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2010-09 |
| Est. Completion | 2019-10-25 |
What the finished NCT02389634 record still lists
NCT02389634 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 3,585-participant average among 21 other Subarachnoid Hemorrhage trials with a reported enrollment target (99% lower).
The record links to 2 conditions, with Subarachnoid Hemorrhage appearing as the primary indexed condition, and to 0 interventions.
NCT02389634 reports a single indexed study location in Arizona.
Frequently Asked Questions
What is clinical trial NCT02389634 about?
NCT02389634 is a clinical study titled "Identification of Novel Molecular Markers for Vasospasm". The purpose of the study is to identify novel genetic and protein markers for the process of cerebral vasospasm following aneurysmal subarachnoid hemorrhage.
What is the current status of trial NCT02389634?
This trial is currently completed. The enrollment target is 50 participants. The study started on 2010-09. Estimated completion is 2019-10-25.
What conditions does trial NCT02389634 study?
This clinical trial studies the following conditions: Subarachnoid Hemorrhage, Cerebral Vasospasm.
Who is sponsoring clinical trial NCT02389634?
This trial is sponsored by St. Joseph's Hospital and Medical Center, Phoenix, which has 44 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02389634 being conducted?
This trial has 1 study location across Arizona. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Subarachnoid Hemorrhage
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02389634's enrollment target sits among peer trials
50 14th of 21 higher than 5 of 21 other Subarachnoid Hemorrhage trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Subarachnoid Hemorrhage trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Hyperpolarized 13C-pyruvate Metabolic MRI With Traumatic Brain Injury
RECRUITING · Phase 1
-
AFFECT Study for Patients With Intraventricular Hemorrhage, Subarachnoid Hemorrhage, Subdural Hematoma, and Ventriculitis
RECRUITING · NA
-
Determinants of Incident Stroke Cognitive Outcomes and Vascular Effects on RecoverY
RECRUITING
-
Auricular VNS Following Subarachnoid Hemorrhage
RECRUITING · NA
-
Optical Coherence Tomography Angiography in Neurological Disease
RECRUITING
-
Impact of NMES and HPRO on Recovery After SAH- Pilot Study
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia